Suchergebnisse

Introduction : disaster whiteness -- Starting points : white power neoliberalism/neoliberal white power -- Immiseration culture, or how the family became a trope and a truncheon -- Racializing family values : strategies for neoliberal takeover -- The "family" at the core of white power utopia -- Conclusions in strange times, or life within the conjuncture of neoliberalism and white power.

Part I. Introductories -- 1. Preface; Kenneth M. Roemer -- 2. Introduction; Patricia Ventura -- 3. Aethiopian Devils Are White: Constructions of Race in Early Modern Utopian Texts; Jane Campbell -- Part II. African American Literatures of Utopia from the Past to the Afrofuture -- 4. The Illusory Promises of Freedom: Frederick Douglass and the Utopia of Liberation; David Lemke -- 5. Intratextual Utopianism in Pauline Hopkins' Of One Blood; Or, the Hidden Self and the Colored American Magazine; Amber Foster -- 6. Inevitable Hell? Eutopia and Race in George S. Schuyler's Black No More; Tarshia Stanley -- 7. Black Power Utopia: Sons of Darkness, Sons of Light, and the Revolutionary Afrofuturism of 1962-1974; Mark Tabone -- 8. Utopianism, Anti-utopianism, and Cultural Appropriation: Mike Resnick's Kirinyaga; Jeffrey Allen Tucker -- 9. Re-Programming the Present: The Dynamism of Black Futurity in Nalo Hopkinson Novels"; Cienna Davis -- 10. Race and Utopia in Mat Johnson's Pym; Julie Fiorelli -- 11. Someone Else's Hell: Utopia in N.K. Jemisin's Dreamblood Duology; Susana Morris -- 12. Afrotopia and Afrofuturism: Seeking a Happy Place in Colson Whitehead's The Underground Rail -- road and Nisi Shawl's Everfair; Isiah Lavender III -- Part III. Utopian Literatures of Race and Ethnicity -- 13. Nineteenth Century American Utopianism and the Attempted Reform of a Native American Tribe: From Fourierist Social Experiment to Mass Murder; Charles W. Nuckolls -- 14. Utopian Citizenship and Contemporary Arab-American Literature; Joseph Donica -- 15. The White Nationalist Utopia and the Reproduction of Victimized Whiteness; Edward K. Chan -- 16. "Strange Times to be a Jew"—Themes of Whiteness, Identity, and Sanctuary in the Imagined Jewish Utopias of Grand Island and Sitka; Justin Nordstrom -- 17. Looking Inward: Charles Yu and the Impossibility of Private Utopias; Betsy Huang -- 18. The Tale of the Tattoo: Latino/Americans, Race, and Utopia in Ink; Tace Hedrick and Karina Vado

Chronic inflammation associated with hepatitis C virus (HCV) infection can lead to disabling liver diseases with progression to liver cirrhosis and hepatocellular carcinoma. Despite the recent availability of more effective and less toxic therapeutic options, in most parts of the world the standard treatment consists of a weekly injection of pegylated interferon a (IFN-alpha) together with a daily dose of ribavirin. HCV patients frequently present circulating non-organ-specific autoantibodies demonstrating a variety of staining patterns in the indirect immunofluorescence assay for antinuclear antibodies (ANA). Between 20% to 40% of HCV patients treated with IFN-a and ribavirin develop autoantibodies showing a peculiar ANA pattern characterized as rods and rings (RR) structures. The aim of this article is to review the recent reports regarding RR structures and anti-rods/rings (anti-RR) autoantibody production by HCV patients after IFN-alpha/ribavirin treatment. Anti-RR autoantibodies first appear around the sixth month of treatment and reach a plateau around the twelfth month. After treatment completion, anti-RR titers decrease/disappear in half the patients and remain steady in the other half. Some studies have observed a higher frequency of anti-RR antibodies in relapsers, i. e., patients in which circulating virus reappears after initially successful therapy. The main target of anti-RR autoantibodies in HCV patients is inosine-5 ' n-monophosphate dehydrogenase 2 (IMPDH2), the rate-limiting enzyme involved in the guanosine triphosphate biosynthesis pathway. Ribavirin ; Brazilian government research foundations National Council for Research and Technology ; Sao Paulo Government agency Sao Paulo State Research Foundation ; Univ Fed Sao Paulo, Escola Paulista Med, Div Rheumatol, Rua Botucatu 740, BR-04023062 Sao Paulo, SP, Brazil ; Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA ; Fleury Med & Hlth Labs, Div Immunol, BR-04102050 Sao Paulo, SP, Brazil ; Univ Fed Sao Paulo, Escola Paulista Med, Div Rheumatol, Rua Botucatu 740, BR-04023062 Sao Paulo, SP, Brazil ; FAPESP: 2011/12448-0 ; FAPESP: 9028-11-0 ; FAPESP: 305064/2011-8 ; FAPESP: 232711/2014-3 ; Web of Science